Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B
- PMID: 9464265
- DOI: 10.1006/bbrc.1997.8016
Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B
Abstract
Human 4-1BB (CD137), a member of the tumor necrosis factor receptor (TNFR) superfamily, costimulates T cell activation. No apparent intrinsic kinase activity is seen with 4-1BB, which suggests that 4-1BB-associated molecules may be involved in 4-1BB-mediated signal transduction. We found that tumor necrosis factor receptor-associated factor (TRAF) 1, TRAF2, and TRAF3, all interacted with the cytoplasmic domain of 4-1BB. Mutation analysis showed that TRAF1, TRAF2, and TRAF3 were associated with one of two runs of acidic residues found in the cytoplasmic domain of 4-1BB. In addition, 4-1BB cross-linking with TCR signal in Jurkat cells and overexpression of 4-1BB in 293 cells were able to induce activation of the nuclear factor-kappa B (NF-kappa B). 4-1BB-mediated NF-kappa B activation was inhibited by a dominant negative-TRAF2 or -NF-kappa B-inducing kinase (NIK). These data suggest that 4-1BB functions may be mediated by NF-kappa B activation, which requires a TRAF2/NIK pathway.
Similar articles
-
CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.Biochemistry. 1998 Aug 25;37(34):11836-45. doi: 10.1021/bi981067q. Biochemistry. 1998. PMID: 9718306
-
TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2874-9. doi: 10.1073/pnas.0500187102. Epub 2005 Feb 11. Proc Natl Acad Sci U S A. 2005. PMID: 15708970 Free PMC article.
-
Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.EMBO J. 1997 Mar 3;16(5):1080-92. doi: 10.1093/emboj/16.5.1080. EMBO J. 1997. PMID: 9118946 Free PMC article.
-
Role of 4-1BB in immune responses.Semin Immunol. 1998 Dec;10(6):481-9. doi: 10.1006/smim.1998.0157. Semin Immunol. 1998. PMID: 9826581 Review.
-
Role of 4-1BB:4-1BB ligand in cancer immunotherapy.Cancer Gene Ther. 2004 Mar;11(3):215-26. doi: 10.1038/sj.cgt.7700670. Cancer Gene Ther. 2004. PMID: 14671675 Review.
Cited by
-
Improving CAR T-Cell Persistence.Int J Mol Sci. 2021 Oct 7;22(19):10828. doi: 10.3390/ijms221910828. Int J Mol Sci. 2021. PMID: 34639168 Free PMC article. Review.
-
Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4), and CD137 in cervical carcinoma.Int J Clin Exp Pathol. 2021 Oct 15;14(10):1038-1047. eCollection 2021. Int J Clin Exp Pathol. 2021. PMID: 34760040 Free PMC article.
-
Design of diversified chimeric antigen receptors through rational module recombination.iScience. 2023 Mar 30;26(4):106529. doi: 10.1016/j.isci.2023.106529. eCollection 2023 Apr 21. iScience. 2023. PMID: 37102149 Free PMC article.
-
The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity.Front Immunol. 2020 Dec 10;11:553715. doi: 10.3389/fimmu.2020.553715. eCollection 2020. Front Immunol. 2020. PMID: 33362756 Free PMC article. Review.
-
TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer.Cancers (Basel). 2022 Aug 22;14(16):4055. doi: 10.3390/cancers14164055. Cancers (Basel). 2022. PMID: 36011046 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous